W.K. Evans
Impact in
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
-
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Diagnosis and Treatment 6
- Lung Cancer Treatments and Mutations 5
-
- Economic and Financial Impacts of Cancer 4
- Health Systems, Economic Evaluations, Quality of Life 4
- Co-authors
- Joseph L. Pater (3 shared papers)Ronald Feld (4 shared papers)Pamela Jean Goodwin (1 shared paper)Ian D. Graham (2 shared papers)George P. Browman (2 shared papers)Frances A. Shepherd (4 shared papers)Jean Alfred Maroun (2 shared papers)E. Ann Mohide (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Lung Cancer (3 papers)Cancer Treatment Reviews (2 papers)European Journal of Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
W.K. Evans
24 papers receiving 494 citations
Peers
Comparison fields: 5 of 44
- Economics and Econometrics 191
- Oncology 120
- Pulmonary and Respiratory Medicine 122
- Public Health, Environmental and Occupational Health 82
- Cancer Research 22
Countries citing papers authored by W.K. Evans
This map shows the geographic impact of W.K. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.K. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.K. Evans more than expected).
Fields of papers citing papers by W.K. Evans
This network shows the impact of papers produced by W.K. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.K. Evans. The network helps show where W.K. Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside W.K. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 123 | |
| 2 | 1998 | 108 | |
| 3 | 1988 | 75 | |
| 4 | 1985 | 36 | |
| 5 | 2000 | 34 | |
| 6 | The cost of managing lung cancer in Canada. | 1995 | 29 |
| 7 | Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module. | 1997 | 27 |
| 8 | 2001 | 13 | |
| 9 | 1999 | 12 | |
| 10 | Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer. | 1992 | 11 |
| 11 | 2000 | 9 | |
| 12 | Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a clinical practice guideline | 2006 | 9 |
| 13 | Chemotherapy for relapsed small cell lung cancer: a clinical practice guideline | 2006 | 9 |
| 14 | A model for estimating the costs and burdens of breast cancer diagnosis and treatment in Canada. | 1993 | 8 |
| 15 | Use of vinorelbine in non-small-cell lung cancer | 1997 | 7 |
| 16 | 2004 | 6 | |
| 17 | 2004 | 4 | |
| 18 | The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a clinical practice guideline | 2012 | 4 |
| 19 | Use of the epidermal growth factor receptor inhibitors gefitinib and erlotinib in the treatment of non-small cell lung cancer: a clinical practice guideline | 2006 | 3 |
| 20 | 1986 | 2 |
About W.K. Evans
W.K. Evans is a scholar working on Pulmonary and Respiratory Medicine, Economics and Econometrics, Oncology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 538 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers), Economic and Financial Impacts of Cancer (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Clinical practice guidelines implementation (3 papers), Lung Cancer Research Studies (3 papers), Smoking Behavior and Cessation (1 paper) and Nausea and vomiting management (1 paper). The work is most often cited by research in Economics and Econometrics (191 citations), Oncology (120 citations), Pulmonary and Respiratory Medicine (122 citations), Public Health, Environmental and Occupational Health (82 citations) and Cancer Research (22 citations). W.K. Evans has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Joseph L. Pater, Ronald Feld, Pamela Jean Goodwin, Ian D. Graham, George P. Browman, Frances A. Shepherd, Jean Alfred Maroun, E. Ann Mohide, D. Ian Hodson and Kathleen I. Pritchard. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Cancer Treatment Reviews, European Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.